Jubilant Ingrevia Share Price

NSE
JUBLINGREA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Jubilant Ingrevia
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
56.36% Gain from 52W Low
-14.8
Dividend yield 1yr %
Above industry Median
0.7

Jubilant Ingrevia Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Jubilant Ingrevia Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
1056.77 Cr
1045.24 Cr
1024.34 Cr
1074.44 Cr
966.4 Cr

Jubilant Ingrevia Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021
4171.1 Cr
4806.06 Cr
4980.85 Cr
686.73 Cr

Jubilant Ingrevia Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
69.37 Cr
59 Cr
48.66 Cr
29.3 Cr
38.53 Cr

Jubilant Ingrevia Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
182.87 Cr
307.53 Cr
476.76 Cr
54.36 Cr
-0.17 Cr
Jubilant Ingrevia Result Highlights
  • Jubilant Ingrevia Ltd reported a 1.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 9.3%.

  • Its expenses for the quarter were down by 0.5% QoQ and up 5.5% YoY.

  • The net profit increased 17.6% QoQ and increased 79.9% YoY.

  • The earnings per share (EPS) of Jubilant Ingrevia Ltd stood at 4.4 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Jubilant Ingrevia shareholding Pattern

Promoter
51.5%
Foreign Institutions
6.9%
Mutual Funds
13.9%
Domestic Institutions
16%
Public
24.9%
Promoter
51.5%
Foreign Institutions
7.2%
Mutual Funds
12.7%
Domestic Institutions
15.5%
Public
25.1%
Promoter
51.5%
Foreign Institutions
6.6%
Mutual Funds
10.6%
Domestic Institutions
14%
Public
27.1%
Promoter
51.5%
Foreign Institutions
6.6%
Mutual Funds
10.2%
Domestic Institutions
13.6%
Public
27.5%
Promoter
51.5%
Foreign Institutions
6.4%
Mutual Funds
9.1%
Domestic Institutions
11.1%
Public
30.2%
Promoter
51.5%
Foreign Institutions
6.3%
Mutual Funds
8.1%
Domestic Institutions
9.2%
Public
32.2%

Jubilant Ingrevia Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
10
Bearish Moving Averages
6
5Day EMA
693.00
10Day EMA
686.30
12Day EMA
683.90
20Day EMA
679.20
26Day EMA
679.40
50Day EMA
690.00
100Day EMA
699.10
200Day EMA
673.00
5Day SMA
697.30
10Day SMA
687.00
20Day SMA
665.90
30Day SMA
667.30
50Day SMA
681.30
100Day SMA
723.20
150Day SMA
723.80
200Day SMA
687.30
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
94884 Rs
226955 Rs
Week Rs
282519 Rs
448617 Rs
Month Rs
187640 Rs
396214 Rs
Resistance & Support
693.32
Pivot
Resistance
First Resistance
709.43
Second Resistance
730.42
Third Resistance
746.53
Support
First Support
672.33
Second support
656.22
Third Support
635.23
Relative Strength Index
52.29
Money Flow Index
67.08
MACD
4.47
MACD Signal
-1.64
Average True Range
31.76
Average Directional Index
14.93
Rate of Change (21)
0.98
Rate of Change (125)
-8.91

Jubilant Ingrevia Company background

Founded in: 2019
Managing director: Mr. Deepak Jain
Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on 23 October 2019 in Uttar Pradesh. The name of Company was changed from Jubilant LSI Limited to Jubilant Ingrevia Limited effective October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, costeffective and conforming to excellent quality standards. The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. The Group has four flagships companies listed on Indian Stock Exchanges Jubilant Ingrevia Limited, Jubilant Pharmova Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. The Companys stateoftheart manufacturing facilities across India offer a range of products and solutions that are innovative, costeffective and quality driven. It established itself as a single point solution for CDMO services for global Pharmaceutical and Agrochemical companies. It is at present across the value chain like Route design, Process Development, Process Optimisation, Scaleup and Commercial Manufacturing of Advance Intermediates for Pharma and Agro and Actives for Agrochemicals. It is a leading supplier of Ethanol to Oil Marketing Companies (OMCs) for Ethanol Blending Programme (EBP) among standalone distilleries in India. The Company is engaged in manufacturing and supply of speciality intermediates, nutrition health solutions and life science chemicals through five manufacturing facilities in India. It offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the Company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The business focuses on three core segments Speciality Chemicals, Nutrition and Health Solutions and Life Science Chemicals. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3, Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of Vitamin B3 and Indias largest manufacturer of Vitamin B4. The Company is a Partner of Choice for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand Phytoshield. The Life Science Ingredients (LSI) business of Jubilant Pharmova Limited was demerged into the Company, (Jubilant Ingrevia Limited) through the Scheme of Amalgamation effective from February 1, 2021. Pursuant to Composite Scheme of Arrangement, 5 subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from the said date.During FY 202223, the Company acquired 37.98% of equity share capital of Mister Veg Foods Private Limited (MVFPL) effective March 16, 2023. It commissioned the 25,000 TPA New Acetic Anhydride Plant in Bharuch, Gujarat.
Read More

Jubilant Ingrevia FAQs

Jubilant Ingrevia share price is ₹688.45 in NSE and ₹689.45 in BSE as on 24/3/2025.

Jubilant Ingrevia share price in the past 1-year return was 49.69. The Jubilant Ingrevia share hit a 1-year low of Rs. 440.3 and a 1-year high of Rs. 885.

The market cap of Jubilant Ingrevia is Rs. 10965.71 Cr. as of 24/3/2025.

The PE ratios of Jubilant Ingrevia is 53.7 as of 24/3/2025.

The PB ratios of Jubilant Ingrevia is 4.76 as of 24/3/2025

The Mutual Fund Shareholding in Jubilant Ingrevia was 13.91% at the end of 24/3/2025.

You can easily buy Jubilant Ingrevia shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Jubilant Ingrevia stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -